Development of an electronic daily uterine fibroid symptom diary

Patient

Volumn 4, Issue 1, 2011, Pages 31-44

  Deal, Linda S ^a,c   Williams, Valerie S L ^b   Fehnel, Sheri E ^b  

^a PFIZER INC   (United States)

^b RTI HEALTH SOLUTIONS   (United States)

^c Janssen Services LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; BLOATING; DYSPAREUNIA; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; FATIGUE; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; OUTCOME ASSESSMENT; POPULATION; PRIORITY JOURNAL; RACE DIFFERENCE; SPOTTING; SYMPTOMATOLOGY; UNITED STATES; UTERUS MYOMA;

ADULT; COMPUTERS, HANDHELD; FEMALE; FOCUS GROUPS; HUMANS; LEIOMYOMA; MIDDLE AGED; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SELF REPORT;

EID: 79951647173     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.2165/11537290-000000000-00000     Document Type: Article

References (37)

1. Stewart EA. Uterine fibroids. Lancet 2001; 357 (9252): 293-8 (Pubitemid 32120866)
2. Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004; 104 (2): 393-406 (Pubitemid 40458890)
3. Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 2005; 48 (2): 312-24 (Pubitemid 40605135)
4. Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.AmJ Obstet Gynecol 2003; 188 (1): 100-7
5. Williams VS, Jones G, Mauskopf J, et al. Uterine fibroids: a review of health-related quality of life assessment. J Womens Health (Larchmt) 2006; 15 (7): 818-29 (Pubitemid 46381700)
6. Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 2006; 108 (4): 930-7 (Pubitemid 44498255)
7. Becker ER, Spalding J, DuChane J, et al. Inpatient surgical treatment patterns for patients with uterine fibroids in the United States, 1998-2002. J Natl Med Assoc 2005; 97 (10): 1336-42 (Pubitemid 41429055)
8. Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep) 2007 Jul; (154): 1-122
9. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30 (6): 473-83
10. Ware Jr JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Boston (MA): The Health Institute, New England Medical Center, 1993
11. No authors listed. EuroQol: a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990; 16 (3): 199-208
12. Brooks R. EuroQol: the current state of play. Health Policy 1996; 37 (1): 53-72 (Pubitemid 26191458)
13. Harding G, Coyne KS, Thompson CL, et al. The responsiveness of the uterine fibroid symptom and healthrelated quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes 2008 Nov 12; 6: 99
14. Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002; 99 (2): 290-300 (Pubitemid 34114003)
15. Broderick JE, Schwartz JE, Vikingstad G, et al. The accuracy of pain and fatigue items across different reporting periods. Pain 2008; 139 (1): 146-57
16. Stone AA, Broderick JE, Shiffman SS, et al. Understanding recall of weekly pain from a momentary assessment perspective: absolute agreement, between- and within-person consistency, and judged change in weekly pain. Pain 2004; 107 (1-2): 61-9 (Pubitemid 38058700)
17. US Department of Health and Human Services. Guidance for industry: patient reported outcome measures. Use in medical product development to support labeling claims. Silver Spring (MD): US Food and Drug Administration, 2009 Dec [online]. Available from URL: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf [Accessed 2010 Jan 29]
18. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. Am Fam Physician 2007; 75 (10): 1503-8 (Pubitemid 46790333)
19. National Women's Health Information Center. Frequently asked questions: uterine fibroids. 2008. Updated 13 May 2008 [online]. Available from URL: shealth.gov/faq/uterine-fibroids.cfm [Accessed 2009 Jan 4]
20. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964; 16: 244-8
21. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97 (8): 734-9 (Pubitemid 20263124)
22. Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995; 85 (6): 977-82
23. Wyatt KM, Dimmock PW, Walker TJ, et al. Determination of totalmenstrual blood loss. Fertil Steril 2001; 76 (1): 125-31
24. National Institute for Health and Clinical Excellence. Heavy menstrual bleeding. Guideline 44. London: NICE, 2007
25. Anastasi A, Urbina S. Psychological testing. 7th ed. Upper Saddle River (NJ): Prentice Hall, 1997
26. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994
27. Greenfield S. Medication error reduction and the use of PDA technology. J Nurs Educ 2007; 46 (3): 127-31
28. Prytherch DR, Smith GB, Schmidt P, et al. Calculating early warning scores: a classroom comparison of pen and paper and hand-held computermethods. Resuscitation 2006; 70 (2): 173-8 (Pubitemid 44219006)
29. Stone AA, Shiffman S, Schwartz JE, et al. Patient noncompliance with paper diaries. BMJ 2002; 324 (7347): 1193-4
30. Cella D, Eton DT, Lai JS, et al. Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage 2002; 24 (6): 547-61 (Pubitemid 36120443)
31. Cella D, Lai JS, Chang CH, et al. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002; 94 (2): 528-38 (Pubitemid 34081385)
32. Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997; 13 (2): 63-74 (Pubitemid 27147321)
33. Cleeland CS. Brief Pain Inventory-Short Form©. Charles S. Cleeland, PhD, Pain Research Group; Interactive Performance Technologies, LLC-All rights reserved, copyright 1991
34. Keller S, Bann CM, Dodd SL, et al. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain 2004; 20 (5): 309-18 (Pubitemid 39108843)
35. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. 2nd ed. New York: Oxford University Press, 1996
36. Tan G, Jensen MP, Thornby JI, et al. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain 2004; 5: 133-7 (Pubitemid 38850184)
37. Williams VS, Smith MY, Fehnel SE. The validity and utility of the BPI interference measures for evaluating the impact of osteoarthritic pain. J Pain Symptom Manage 2006; 31 (1): 48-57 (Pubitemid 43143298)